文献速递颈动脉与弓上血管

颈动脉内膜切除术与经股动脉颈动脉支架置入术在医疗保险匹配数据库中的长期结局比较

Long-term outcomes of carotid endarterectomy vs transfemoral carotid stenting in a Medicare-matched database.
PubMed 文献 · J Vasc Surg · 2023-08-25

基于VQI-VISION医疗保险匹配数据库,纳入2003年1月至2018年12月首次颈动脉血运重建患者,比较颈动脉内膜切除术(CEA)与经股动脉颈动脉支架置入术(TFCAS)的长期结局。CEA组72,615例,TFCAS组7,531例。10年随访中CEA与死亡、卒中及死亡或卒中复合终点风险显著降低相关,支持CEA作为一线血运重建术式。

要点

  • CEA与TFCAS相比10年死亡风险显著降低(57.8% vs 70.4%,aHR 0.46,95%CI 0.41-0.52,P<.001)。
  • CEA与TFCAS相比10年卒中风险显著降低(21.3% vs 26.6%,aHR 0.63,95%CI 0.57-0.69,P<.001)。
  • 倾向匹配队列4年复合终点CEA组低于TFCAS组(34.6% vs 46.8%,HR 0.53,95%CI 0.46-0.62)。

核心结论

  • 在北美真实世界数据中,与TFCAS相比,CEA与更好的长期生存和更少的卒中相关。
  • 作者认为这些发现支持继续将CEA作为一线血运重建术式。

研究设计与样本

  • 基于VQI-VISION医疗保险匹配数据库的回顾性分析,纳入2003年1月至2018年12月首次CEA或TFCAS患者。
  • 排除既往颈动脉血运重建史、非经股动脉支架、未使用远端栓塞保护装置的支架、多发或非动脉粥样硬化性病变及同期手术者。
  • 共纳入80,146例颈动脉血运重建,其中CEA 72,615例,TFCAS 7,531例。
  • 采用倾向评分匹配及按症状状态分层分析。

主要发现

  • 10年死亡:CEA组57.8% vs TFCAS组70.4%(aHR 0.46,95%CI 0.41-0.52,P<.001)。
  • 10年卒中:CEA组21.3% vs TFCAS组26.6%(aHR 0.63,95%CI 0.57-0.69,P<.001)。
  • 10年死亡或卒中复合终点:CEA组65.3% vs TFCAS组76.5%(HR 0.49,95%CI 0.44-0.55,P<.001)。
  • 倾向匹配队列4年复合终点:CEA组34.6% vs TFCAS组46.8%(HR 0.53,95%CI 0.46-0.62)。
  • 10年复合终点按症状分层:无症状者CEA组63.2% vs TFCAS组74.9%(HR 0.49,95%CI 0.43-0.58,P<.001);有症状者CEA组69.9% vs TFCAS组78.3%(HR 0.51,95%CI 0.45-0.59,P<.001)。

临床怎么用

  • 作者认为这些发现支持继续将CEA作为一线血运重建术式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid endarterectomy (CEA) is associated with lower risk of perioperative stroke compared with transfemoral carotid artery stenting (TFCAS) in the treatment of carotid artery stenosis. However, there is discrepancy in data regarding long-term outcomes. We aimed to compare long-term outcomes of CEA vs TFCAS using the Medicare-matched Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database. METHODS: We assessed patients undergoing first-time CEA or TFCAS in Vascular Quality Initiative Vascular-Vascular Implant Surveillance and Interventional Outcomes Network from January 2003 to December 2018. Patients with prior history of carotid revascularization, nontransfemoral stenting, stenting performed without distal embolic protection, multiple or nonatherosclerotic lesions, or concomitant procedures were excluded. The primary outcome of interest was all-cause mortality, any stroke, and a combined end point of death or stroke. We additionally performed propensity score matching and stratification based on symptomatic status. RESULTS: A total of 80,146 carotid revascularizations were performed, of which 72,615 were CEA and 7531 were TFCAS. CEA was associated with significantly lower risk of death (57.8% vs 70.4%, adjusted hazard ratio [aHR], 0.46; 95% confidence interval [CI], 0.41-0.52; P < .001), stroke (21.3% vs 26.6%; aHR, 0.63; 95% CI, 0.57-0.69; P < .001) and combined end point of death and stroke (65.3% vs 76.5%; HR, 0.49; 95% CI, 0.44-0.55; P < .001) at 10 years. These findings were reflected in the propensity-matched cohort (combined end point: 34.6% vs 46.8%; HR, 0.53; 95% CI, 0.46-0.62) at 4 years, as well as stratified analyses of combined end point by symptomatic status (asymptomatic: 63.2% vs 74.9%; HR, 0.49; 95% CI, 0.43-0.58; P < .001; symptomatic: 69.9% vs 78.3%; HR, 0.51; 95% CI, 0.45-0.59; P < .001) at 10 years. CONCLUSIONS: In this analysis of North American real-world data, CEA was associated with greater long-term survival and fewer strokes compared with TFCAS. These findings support the continued use of CEA as the first-line revascularization procedure.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yei KS, Janssen C, Elsayed N, et al. Long-term outcomes of carotid endarterectomy vs transfemoral carotid stenting in a Medicare-matched database. J Vasc Surg. 2023. PMID: 37634620. doi:10.1016/j.jvs.2023.08.118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。